Rocket Pharmaceuticals Inc Net Asset Quality Index
Rocket Pharmaceuticals Inc net asset quality index. Rocket Pharmaceuticals Inc (RCKT) has a Net Asset Quality Index of 87.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $423.10 Million minus total liabilities of $54.27 Million yields net assets of $368.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Rocket Pharmaceuticals Inc's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Rocket Pharmaceuticals Inc (2012–2025)
Net asset quality index of Rocket Pharmaceuticals Inc from 2012 to 2025. This chart shows how Rocket Pharmaceuticals Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 87.2%, representing net assets of $368.83 Million against total assets of $423.10 Million USD. Check how strategically is Rocket Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Rocket Pharmaceuticals Inc Net Asset Quality Index by Year (2012–2025)
Rocket Pharmaceuticals Inc net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Rocket Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Rocket Pharmaceuticals Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.9% | $277.22 Million | $330.45 Million | $53.23 Million | ▼ -3.9 pp |
| 2024 | 87.8% | $463.23 Million | $527.70 Million | $64.47 Million | ▲ +0.8 pp |
| 2023 | 87.0% | $492.57 Million | $566.34 Million | $73.77 Million | ▼ -1.8 pp |
| 2022 | 88.7% | $489.69 Million | $551.81 Million | $62.12 Million | ▼ -2.7 pp |
| 2021 | 91.5% | $454.72 Million | $497.02 Million | $42.30 Million | ▲ +6.3 pp |
| 2020 | 85.2% | $503.52 Million | $590.82 Million | $87.31 Million | ▲ +2.6 pp |
| 2019 | 82.6% | $307.30 Million | $372.12 Million | $64.82 Million | ▲ +5.4 pp |
| 2018 | 77.2% | $194.04 Million | $251.31 Million | $57.28 Million | ▲ +30.3 pp |
| 2017 | 46.9% | $47.76 Million | $101.78 Million | $54.01 Million | ▼ -9.5 pp |
| 2016 | 56.4% | $73.17 Million | $129.65 Million | $56.48 Million | ▼ -39.6 pp |
| 2015 | 96.0% | $108.81 Million | $113.32 Million | $4.51 Million | ▲ +1030.1 pp |
| 2014 | -934.0% | $-51.56 Million | $5.52 Million | $57.08 Million | ▼ -631.7 pp |
| 2013 | -302.4% | $-38.90 Million | $12.86 Million | $51.76 Million | ▲ +1874.3 pp |
| 2012 | -2176.6% | $-30.93 Million | $1.42 Million | $32.35 Million | — |